InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: None

Saturday, 07/02/2022 5:12:37 PM

Saturday, July 02, 2022 5:12:37 PM

Post# of 425795
None of the most discussed topics - ongoing studies, STAT article, management, etc. - are important on a real (long-) term. All of these are micro-management ... the worst thing that any company could do ...

They have to - and they are doing it - focus on:
- US exclusivity (45% by 3/21/2021) and optimal operation* method (it is - due the current world - is significantly different than a 1 year ago (generics are a part of it only)
- EU roll-out ... as more likely they will get $160-170 USD price (before mandatory discounts, rebates) in all important countries (France, Germany, Italy, etc.)
- a much as possible licensing / cooperation in non GIA countries / territories

The pps will follow these ...

Best,
G

ps.: Do anybody really think (I know a lot of you hope ...) that Denner will change the world ... ? Do he would like to change the world? Hello!!! He voted "abstain", not "against" ...

ps II. the most silly, laughable posts when it is about other posters ...

Disclosure: I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for it.

Notice: This post is not investment advice, and not a recommendation to neither buy nor hold nor sell.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News